Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes
Genprex(GNPX) Prnewswire·2024-09-04 21:29Intends to Create Two Distinct Businesses, Re-Focusing Genprex on its Oncology Clinical Development ProgramNew Subsidiary to Focus on Developing Novel Gene Therapy for DiabetesAUSTIN, Texas, Sept. 4, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its intention to transfer the Company's diabetes clinical development program and its diabete ...